Compare DRUG & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRUG | PNTG |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 856.4M | 1.0B |
| IPO Year | N/A | N/A |
| Metric | DRUG | PNTG |
|---|---|---|
| Price | $76.68 | $30.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $106.75 | $36.50 |
| AVG Volume (30 Days) | 125.9K | ★ 334.2K |
| Earning Date | 02-10-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.47 |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $847,274,000.00 |
| Revenue This Year | N/A | $36.42 |
| Revenue Next Year | N/A | $23.99 |
| P/E Ratio | ★ N/A | $40.37 |
| Revenue Growth | N/A | ★ 29.89 |
| 52 Week Low | $23.18 | $21.18 |
| 52 Week High | $123.75 | $31.94 |
| Indicator | DRUG | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 43.97 | 58.41 |
| Support Level | $72.08 | $26.67 |
| Resistance Level | $81.00 | $30.53 |
| Average True Range (ATR) | 4.85 | 1.40 |
| MACD | -1.57 | 0.08 |
| Stochastic Oscillator | 26.02 | 67.68 |
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.